In this episode, Ayesha discussed Elon Musk’s recent revelation that in addition to fasting, he also used Novo Nordisk’s weight loss drug Wegovy to help him get “lean and fit.” In response to a question on Twitter, Musk disclosed that both fasting and Wegovy were the secrets to his recent weight loss. Musk is not affiliated with Novo so his endorsement of the drug came as a surprise, and could also be problematic according to some industry experts. Hear more about the story in this episode.
The editorial team also learned about the FDA approval of Nevro Corp’s AI-based spinal cord stimulation (SCS) system for the treatment of chronic pain. Nevro says its Senza HFX iQ system is the first and only AI-based SCS system that personalizes care by learning from patients. The implantable device delivers neurostimulation via the company’s proprietary high frequency pulse technology that has been evaluated in more than 90,000 patients.
Read the full articles here:
Subscribe to the Xtalks Life Science Podcast to never miss a new episode.